Please login to the form below

Not currently logged in
Email:
Password:

President Trump

This page shows the latest President Trump news and features for those working in and with pharma, biotech and healthcare.

FDA takes aim at pharma’s biosimilar-delaying tactics

FDA takes aim at pharma’s biosimilar-delaying tactics

The obstructive practices were referred to as ‘gaming’ in President Trump’s blueprint document which was unveiled earlier this year, as part of a package of measures that are aimed at ... Reference pricing is one of the measures being considered in

Latest news

  • Reference price bill tabled in US House and Senate Reference price bill tabled in US House and Senate

    making it less likely that President Trump’s plans to restrict drug prices would make it onto the legislature. ... due to high deductibles and co-insurance”, which is another of Trump’s proposals.

  • Democrats regain control of House in mid-terms Democrats regain control of House in mid-terms

    The results of the US mid-terms are mostly in, and the headline news is that the Republicans no longer have control of the House of Representatives, limiting President Trump’s ... While an anticipated ‘blue wave’ of Democrat support didn’t really

  • US pricing plan slammed for imposing “foreign price controls” US pricing plan slammed for imposing “foreign price controls”

    Trump returns to popular theme ahead of mid-term elections. President Trump’s latest plan to bring down the cost of medicines in the US has drawn fire from the drug ... Last week, Trump unveiled proposals to bring US prices for drugs covered by

  • US says medicine ads should include list prices US says medicine ads should include list prices

    The measure is intended to create better incentives for lowering prices, which is one of the four pillars of President Trump’s blueprint for pricing controls introduced in May, along with ... The move ramps up pressure on the industry on an issue that

  • Biotech leaders jump into US free speech debate Biotech leaders jump into US free speech debate

    News outlets – including The Guardian in the UK – banded together in August to counter what they says is a concerted campaign by President Donald Trump to undermine the media, repeatedly calling ... Trump responded to the campaign in typical style,

More from news
Approximately 3 fully matching, plus 40 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Current global president, worldwide research and development and medical, Mikael Dolsten, will also become chief medical officer. ... This was because Read had agreed to reverse previously announced price increases after being telephoned by President

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    Its highly fragmented nature leaves it ripe for further M&A activity - led by emboldened and cash-rich US firms if President Trump, via a low ‘repatriation tax’, opens the door ... And then there is the problem of public opinion. “We have a

  • Focus on the fundamentals Focus on the fundamentals

    Brexit, Trump becoming president and in France a movement that did not exist two years ago holding the parliamentary majority.

  • Pharma deals continue to slide Pharma deals continue to slide

    With the dysfunctional political system in the US it is hardly surprising that eight months following President Trump’s inauguration, the repeal of Obamacare has been dropped and the pricing and ... Similarly, the Euro is now around 10% stronger

  • US health reforms US health reforms

    One of the things I think industry is worried about is if Congress and the President can’t get a health bill passed, do they turn to drug pricing because that ... added. President Trump himself has frequently called for lower drug prices. “Once

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics